DMAAR — Drugs Made In America Acquisition Corp. Rights
$0.1000+4.71%
Last close: · regular session
Last 60 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for DMAAR in the TickerWise workspace.
Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
Company profile
- Sector: Financial Services
- Industry: Shell Companies
- Country: US
- Exchange: NASDAQ
- Website: https://dmaacorp.com
Latest SEC filings for DMAAR
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.